KCG
CELG

Knight Capital Group’s Celgene Corp CELG Stock Holding History

Knight Capital Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$3.24M Buy
+55,434
New +$3.34M 0.06% 301

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Knight Capital Group's CELG Position: Q2 2013 in Review

Knight Capital Group opened a new position in Celgene Corp (CELG) in Q2 2013: 55,434 shares worth $3.24M. The stake represents 0.06% of the portfolio and ranks #301 among its holdings.

866 funds tracked by Wall St. Rank hold CELG as of Q2 2013.

  • Knight Capital Group held 55,434 shares of Celgene Corp worth $3.24M as of Q2 2013.
  • Celgene Corp was a new Knight Capital Group position in Q2 2013.
  • Celgene Corp made up 0.06% of Knight Capital Group's portfolio in Q2 2013, its #301 holding.
  • 866 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.